Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. 2003

Dong-Youn Hwang, and Paul Ardayfio, and Un Jung Kang, and Elena V Semina, and Kwang-Soo Kim
Molecular Neurobiology Laboratories, McLean Hospital and Program in Neuroscience, Harvard Medical School, Belmont, MA 02478, USA.

Dopaminergic (DA) neurons in the ventral midbrain nuclei, substantia nigra pars compacta (SNc, A9) and ventral tegmental area (VTA, A10), play important roles in the control of movement, emotion, cognition, and reward related behavior. Although several transcription factors have been shown to be critical for midbrain DA neuron development, there has been no report of factor(s) that differentially regulate individual DA neuronal groups. Based on its highly restricted expression in the SNc and VTA in the brain, we hypothesize that the homeobox transcription factor Pitx3 may critically regulate the development of ventral midbrain DA neurons. In this study, we report that in Pitx3-deficient ak/ak mice, DA neurons in the SNc and the nigrostriatal pathway fail to develop properly, and DA levels are reduced to 10% of the wild type mice in the dorsal striatum. On the contrary, A10 neurons are intact in ak/ak mice and DA levels within their projection areas are not affected. This region-specific defect was already evident in newborn mice, suggesting that the defect had occurred during the early stages of mouse development. Taken together, our results indicate that Pitx3 is the first known transcription factor that may critically and selectively control proper development of A9 DA neurons and the nigrostriatal pathway. This observation is of great importance in understanding the mechanisms of DA neuron development and may also help us to understand the mechanism of selective degeneration of A9 DA neurons in Parkinson's disease and to devise novel therapeutic approaches for the disorder.

UI MeSH Term Description Entries
D009434 Neural Pathways Neural tracts connecting one part of the nervous system with another. Neural Interconnections,Interconnection, Neural,Interconnections, Neural,Neural Interconnection,Neural Pathway,Pathway, Neural,Pathways, Neural
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005801 Genes, Homeobox Genes that encode highly conserved TRANSCRIPTION FACTORS that control positional identity of cells (BODY PATTERNING) and MORPHOGENESIS throughout development. Their sequences contain a 180 nucleotide sequence designated the homeobox, so called because mutations of these genes often results in homeotic transformations, in which one body structure replaces another. The proteins encoded by homeobox genes are called HOMEODOMAIN PROTEINS. Genes, Homeotic,Homeobox Sequence,Homeotic Genes,Genes, Homeo Box,Homeo Box,Homeo Box Sequence,Homeo Boxes,Homeobox,Homeoboxes,Hox Genes,Sequence, Homeo Box,Gene, Homeo Box,Gene, Homeobox,Gene, Homeotic,Gene, Hox,Genes, Hox,Homeo Box Gene,Homeo Box Genes,Homeo Box Sequences,Homeobox Gene,Homeobox Genes,Homeobox Sequences,Homeotic Gene,Hox Gene,Sequence, Homeobox,Sequences, Homeo Box,Sequences, Homeobox
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D001035 Aphakia Absence of crystalline lens totally or partially from field of vision, from any cause except after cataract extraction. Aphakia is mainly congenital or as result of LENS DISLOCATION AND SUBLUXATION. Aphakic Eye,Aphakic Eye, Post-traumatic,Aphakic Eye, Traumatic,Aphakias,Aphakic Eye, Post traumatic,Aphakic Eyes,Aphakic Eyes, Post-traumatic,Eye, Aphakic,Eye, Traumatic Aphakic,Post-traumatic Aphakic Eye,Post-traumatic Aphakic Eyes,Traumatic Aphakic Eye,Traumatic Aphakic Eyes
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription

Related Publications

Dong-Youn Hwang, and Paul Ardayfio, and Un Jung Kang, and Elena V Semina, and Kwang-Soo Kim
April 2003, Proceedings of the National Academy of Sciences of the United States of America,
Dong-Youn Hwang, and Paul Ardayfio, and Un Jung Kang, and Elena V Semina, and Kwang-Soo Kim
September 1995, Proceedings of the National Academy of Sciences of the United States of America,
Dong-Youn Hwang, and Paul Ardayfio, and Un Jung Kang, and Elena V Semina, and Kwang-Soo Kim
March 2004, Development (Cambridge, England),
Dong-Youn Hwang, and Paul Ardayfio, and Un Jung Kang, and Elena V Semina, and Kwang-Soo Kim
August 2000, The Journal of comparative neurology,
Dong-Youn Hwang, and Paul Ardayfio, and Un Jung Kang, and Elena V Semina, and Kwang-Soo Kim
September 2009, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Dong-Youn Hwang, and Paul Ardayfio, and Un Jung Kang, and Elena V Semina, and Kwang-Soo Kim
January 2007, Progress in brain research,
Dong-Youn Hwang, and Paul Ardayfio, and Un Jung Kang, and Elena V Semina, and Kwang-Soo Kim
November 2017, The Journal of comparative neurology,
Dong-Youn Hwang, and Paul Ardayfio, and Un Jung Kang, and Elena V Semina, and Kwang-Soo Kim
January 2009, Acta neurobiologiae experimentalis,
Dong-Youn Hwang, and Paul Ardayfio, and Un Jung Kang, and Elena V Semina, and Kwang-Soo Kim
September 1991, Experimental neurology,
Dong-Youn Hwang, and Paul Ardayfio, and Un Jung Kang, and Elena V Semina, and Kwang-Soo Kim
September 2015, Life sciences,
Copied contents to your clipboard!